Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer (Q36972046)
Jump to navigation
Jump to search
scientific article published on 03 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer |
scientific article published on 03 December 2011 |
Statements
1 reference
Phase 2 study of neoadjuvant treatment with NOV-002 in combination with doxorubicin and cyclophosphamide followed by docetaxel in patients with HER-2 negative clinical stage II-IIIc breast cancer (English)
1 reference
A J Montero
1 reference
C M Diaz-Montero
1 reference
Y E Deutsch
1 reference
J Hurley
1 reference
L G Koniaris
1 reference
T Rumboldt
1 reference
S Yasir
1 reference
M Jorda
1 reference
E Garret-Mayer
1 reference
E Avisar
1 reference
J Slingerland
1 reference
O Silva
1 reference
C Welsh
1 reference
K Schuhwerk
1 reference
P Seo
1 reference
M D Pegram
1 reference
S Glück
1 reference
3 December 2011
1 reference
1 reference
215-223
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference